Jump Financial, LLC Fulcrum Therapeutics, Inc. Transaction History

Jump Financial, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.18 - $9.74 $299,495 - $917,322	-94,181 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $378,755 - $589,667	63,337 Added 205.35%	94,181 $583,000
Q1 2024 May 13, 2024	BUY	$6.7 - $12.0 $206,654 - $370,128	30,844 New	30,844 $291,000
Q3 2023 Oct 21, 2024	SELL	$3.25 - $6.08 $7,770 - $14,537	-2,391 Reduced 2.54%	91,790 $407,000
Q3 2023 Nov 07, 2023	BUY	$3.25 - $6.08 $298,317 - $558,083	91,790 New	91,790 $407,000
Q2 2022 Aug 09, 2022	BUY	$4.2 - $24.0 $121,800 - $696,000	29,000 New	29,000 $142,000
Q1 2022 May 12, 2022	SELL	$9.96 - $23.65 $108,384 - $257,359	-10,882 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$14.0 - $28.44 $152,348 - $309,484	10,882 New	10,882 $193,000
Q3 2021 Nov 12, 2021	SELL	$7.28 - $30.97 $92,448 - $393,288	-12,699 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $102,734 - $152,388	12,699 New	12,699 $133,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.